33
Wang G#, Wang Q#, Wang Y#, Liu C#, Wang L#, Chen H#, Jiao T, Hu C, Lei X, Guo L, Ren L, Li M , Zhao Y, Zeng X, Zhang D, Cao B*, Wang J*. Presence of Anti-MDA5 Antibody and Its Value for the Clinical Assessment in Patients With COVID-19: A Retrospective Cohort Study. frontiersin in Immunology. published: 20 December 2021 doi: 10.3389/fimmu.2021.791348
34
Mu S#, Hu L#, Zhang Y#, Liu Y#, Cui X#, Zou X#, Wang Y, Lu B, Zhou S, Liang X, Liang C, Nick Xiao, Justin O'Grady, Shela Lee*, Cao B*. Prospective Evaluation of a Rapid Clinical Metagenomics Test for Bacterial Pneumonia. Front Cell Infect Microbiol.2021 Oct 19;11:684965. doi: 10.3389/fcimb.2021.684965. eCollection 2021.
35
Sun L#, Li L, Du S, Liu Y, Cao B*. An evaluation of the Unyvero pneumonia system for rapid detection of microorganisms and resistance markers of lower respiratory infections-a multicenter prospective study on ICU patients. Eur J Clin Microbiol Infect Dis. 2021 May 1. doi: 10.1007/s10096-021-04259-6. Online ahead of print.
36
Li H#, Cui X, Sun L, Deng X, Liu S, Zou X, Li B, Wang C, Wang Y, Liu Y, Lu B*, Cao B*. High concentration of Cas12a effector tolerates more mismatches on ssDNA. FASEB J. 2021 Jan;35(1):e21153. doi: 10.1096/fj.202001475R. Epub 2020 Nov 6.
37
Guo L#, Wang Y#, Kang L#, Hu Y#, Wang L#, Zhong J#, Chen H#, Ren L, Gu X, Wang G, Wang C, Dong X, Wu C, Han L, Wang Y, Fan G, Zou X, Li H, Xu J, Jin Q, Cao B*, Wang J*. Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study. Emerg Microbes Infect. 2021 Dec;10(1):664-676. doi: 10.1080/22221751.2021.1905488.
38
Jiang R#, Han B, Dou C, Zhou F, Cao B*, Li X*. Analysis of antibiotic usage for viral community-acquired pneumonia in adults. Front Med. 2021 Feb;15(1):139-143. doi: 10.1007/s11684-019-0736-2. Epub 2020 Jun 13.
39
Shang L#, Gu X#, Du S, Wang Y, Cao B*, Wang C*, for CAP-China Network. The efficacy and safety of therapeutic lung lavage for exogenous lipoid pneumonia: A systematic review. Clin Respir J. 2021 Feb;15(2):134-146. doi: 10.1111/crj.13273. Epub 2021 Feb 2.
40
Huang L#, Gu X, Wang Y, Huang C, Bin Cao B*. Long-term effects of COVID-19 on kidney function - Authors' reply. Lancet. 2021 May 15;397(10287):1807-1808. doi: 10.1016/S0140-6736(21)00875-8.
41
Huang C#, Huang L#, Wang Y#, Li X#, Ren L#, Gu X#, Kang L#, Guo L#, Liu M#, Zhou X, Luo J, Huang Z, Tu S, Zhao, Y, Chen L, Xu D, Li Y, L C, Peng L, Li Y, Xie W, Cui D, Shang L, Fan g, Xu J, Wang G, Wang Y, Zhang J, Wang C, Wang J*, Zhang D*, Cao B*. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021 Jan 16;397(10270):220-232; doi: 10.1016/S0140-6736(20)32656-8
42
Zhao J#, Zhang Y, Fan Y, Han J, Xiong Z, Liu X, Li B, Lu B*, Cao B*. Characterization of an NDM-5-producing hypervirulent Klebsiella pneumoniae sequence type 65 clone from a lung transplant recipient. Emerg Microbes Infect. 2021 Dec;10(1):396-399. doi: 10.1080/22221751.2021.1889932.
43
Han X#, Chen L, Wang Y, Li H, Wang H, Xing X, Zhang C, Suo L, Wang J, Yu G, Wang G, Yao X, Yu H, Wang L, Liu X*, Cao B*, CAP-China Network. Cost Effectiveness of Different Initial Antimicrobial Regimens for Elderly Community-Acquired Pneumonia Patients in General Ward. Infect Drug Resist. 2021 May 18;14:1845-1853. doi: 10.2147/IDR.S302852. eCollection 2021.
44
Huang L#,Cao B*. Post-acute conditions of patients with COVID-19 not requiring hospital admission. Lancet Infect Dis. 2021 May 10;S1473-3099(21)00225-5. doi: 10.1016/S1473-3099(21)00225-5. Online ahead of print.
45
Shang L#, David Chien Lye,Cao B*. Contemporary narrative review of treatment options for COVID-19. Respirology. 2021 Aug;26(8):745-767. doi: 10.1111/resp.14106. Epub 2021 Jul 8.
46
Gu X, Cao B. In-hospital complications associated with COVID-19. Lancet. 2021 Jul 17;398(10296):188-190. doi: 10.1016/S0140-6736(21)00983-1.
47
Xu J#, Cao B*. Letter from China: Managing the second-wave COVID-19 outbreak in Beijing. Respirology. 2021 Jan 5. doi: 10.1111/resp.14002. Online ahead of print.
48
Liu S#, Huang Z#, Deng X, Zou X, Li H, Mu S, Cao B*. Identification of key candidate biomarkers for severe influenza infection by integrated bioinformatical analysis and initial clinical validation. J Cell Mol Med. 2021 Jan 14. doi: 10.1111/jcmm.16275. Online ahead of print.
